# FDA Inspection 858888 - Osteogenics Biomedical, Inc. - December 10, 2013

Source: https://www.keypedia.com/records/fda_inspections/osteogenics-biomedical-inc/3d1f3ef4-1a46-4076-b662-a2d1f4c21b65
Source feed: FDA_Inspections

> FDA Inspection 858888 for Osteogenics Biomedical, Inc. on December 10, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 858888
- Company Name: Osteogenics Biomedical, Inc.
- Inspection Date: 2013-12-10
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1057041 - 2018-05-23](https://www.keypedia.com/records/fda_inspections/osteogenics-biomedical-inc/7858f607-2fe4-4c0c-aa16-905ac38db0cb)
- [FDA Inspection 755668 - 2011-12-02](https://www.keypedia.com/records/fda_inspections/osteogenics-biomedical-inc/3d8b62b3-071d-496d-b2ab-72f6e19ff69a)
- [FDA Inspection 593365 - 2009-06-12](https://www.keypedia.com/records/fda_inspections/osteogenics-biomedical-inc/f428bedc-adb3-48f3-b9c9-8f059ec21771)

Company: https://www.keypedia.com/companies/osteogenics-biomedical-inc/e7aeb9a6-0535-493e-85d7-0fabe47f9c8c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d